Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Han BiomedicalROCO:6999 +4.63%26 PB Ratio is 2.61 as of Aug. 20, 2026, which is 16% below its 10-year median of 3.09. GuruFocus rates ROCO:6999 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 1,214 Biotechnology companies, Han Biomedical ranks better than 56.67% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-20), Han Biomedical's share price is NT$29.40. Han Biomedical's Book Value per Share for the quarter that ended in Dec. 2025 was NT$11.25. Hence, Han Biomedical's PB Ratio of today is 2.61.
Good Sign:
Han Biomedical Inc stock PB Ratio (=2.5) is close to 3-year low of 2.45.
The historical rank and industry rank for Han Biomedical's PB Ratio or its related term are showing as below:
ROCO:6999'
s PB Ratio Range Over the Past 10 Years
Min: 2.45 Med: 3.09 Max: 4.1
Current: 2.62
During the past 5 years, Han Biomedical's highest PB Ratio was 4.10. The lowest was 2.45. And the median was 3.09.
ROCO:6999's PB Ratio is ranked better than 56.67% of 1214
companies
in the Biotechnology industry
Industry Median: 2.94
vs ROCO:6999: 2.62
During the past 12 months, Han Biomedical's average Book Value Per Share Growth Rate was 4.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 11.80% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Han Biomedical was 15.60% per year. The lowest was 11.80% per year. And the median was 13.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Han Biomedical PB Ratio Related Terms
Han Biomedical PB Ratio Historical Data
* Premium members only.
The historical data trend for Han Biomedical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6999 vs VRTX, REGN, RVMD: PB Ratio Comparison
For the Biotechnology subindustry, Han Biomedical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Han Biomedical PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Han Biomedical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Han Biomedical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Han Biomedical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Han Biomedical (ROCO:6999) has a PB Ratio of 2.61 as of Aug. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Han Biomedical and its competitors. This is 16% below median its historical median of 3.09. Over the past decade, Han Biomedical's PB Ratio has ranged from 2.45 to 4.10. According to the industry distribution chart, Han Biomedical ranks #526 out of 1214 companies in the Biotechnology industry, placing it in the top 43.3%.
Is Han Biomedical's PB Ratio too high?
Han Biomedical's current PB Ratio of 2.61 is 16% below median its 10-year median of 3.09. Over the past 10 years, this metric has ranged from a low of 2.45 to a high of 4.10. The Biotechnology industry median PB Ratio is 2.94. Han Biomedical's value of 2.61 is 11.2% below this industry median. Based on the distribution chart, Han Biomedical ranks #526 out of 1214 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Han Biomedical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #526 out of 1214 companies for PB Ratio. This puts Han Biomedical in the upper half of its industry. The industry median PB Ratio is 2.94. Han Biomedical's value of 2.61 is 11.2% below this benchmark. Historically, Han Biomedical's own PB Ratio has ranged from 2.45 to 4.10 over the past decade. While the company's 10-year median is 3.09 vs. the industry median of 2.94, Han Biomedical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.94, based on 1,214 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Han Biomedical's current PB Ratio of 2.61 is 11.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Han Biomedical and its competitors. For the Biotechnology industry, the median PB Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Han Biomedical's current PB Ratio is 2.61, which is 16% below median its own 10-year median of 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current PB Ratio of 2.61. The current PB Ratio is 2.61, which is 16% below median its 10-year median of 3.09 and 11.2% below the Biotechnology industry median of 2.94. Han Biomedical's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current PB Ratio is 2.61 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6999 has been successfully added to your 
